Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 8314479.
- Also identified by PMC identifier 1374037.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a study of 87 patients with chronic hepatitis C, 12 months' treatment with interferon alfa-2b at a dose of 6 million units (MU) three times per week seemed to be more effective than treatment with 3 MU three times a week for two months plus 1.5 MU three times a week for 10 months in increasing the percentage of long term responders. The percentage of patients in whom alanine amino-transferase activities returned to normal was highest in the 6 MU group, as was the percentage of responders who sustained this normal activity after treatment. Side effects were moderate and self-limited in most patients.
Medical subject headings
- Hepatitis C
- Hepatitis, Chronic
- Interferon-alpha